D. Richard Lachno

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

John T. Brandt, Sandra Close, Stephen J. Iturria et al. · Journal of Thrombosis and Haemostasis · 2007 · 726 citations

Medicine, Genetics, Pharmacodynamic Response +6

CSF biomarker variability in the Alzheimer's Association quality control program

Niklas Mattsson, Ulf Andréasson, Staffan Persson et al. · Alzheimer s & Dementia · 2013 · 380 citations · Full text

Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation

Ryszard T. Smoleński, D. Richard Lachno, S.J.M. Ledingham et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1990 · 319 citations

Biochemistry, High-performance Liquid Chromatography, Bioanalysis +10

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics

Linan Song, D. Richard Lachno, David Hanlon et al. · Alzheimer s Research & Therapy · 2016 · 82 citations · Full text

Derivation of cutoffs for the Elecsys^® amyloid β (1–42) assay in Alzheimer's disease

Leslie M. Shaw, Teresa Waligórska, Leona Fields et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2018 · 78 citations · Full text